Precipio Inc (PRPO) - Total Assets
Based on the latest financial reports, Precipio Inc (PRPO) holds total assets worth $21.15 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Precipio Inc book value and equity for net asset value and shareholders' equity analysis.
Precipio Inc - Total Assets Trend (1999–2024)
This chart illustrates how Precipio Inc's total assets have evolved over time, based on quarterly financial data.
Precipio Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Precipio Inc's total assets of $21.15 Million consist of 20.3% current assets and 79.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.2% |
| Accounts Receivable | $799.00K | 4.7% |
| Inventory | $724.00K | 4.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $11.87 Million | 69.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1999–2024)
This chart illustrates how Precipio Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PRPO market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Precipio Inc's current assets represent 20.3% of total assets in 2024, a decrease from 54.6% in 1999.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2024, up from 0.8% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 69.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is intangible assets at 69.8% of total assets.
Precipio Inc Competitors by Total Assets
Key competitors of Precipio Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Precipio Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.27 | 0.73 | 0.90 |
| Quick Ratio | 1.10 | 0.60 | 0.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.22 Million | $-1.22 Million | $-452.00K |
Precipio Inc - Advanced Valuation Insights
This section examines the relationship between Precipio Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.94 |
| Latest Market Cap to Assets Ratio | 1.86 |
| Asset Growth Rate (YoY) | -6.1% |
| Total Assets | $17.00 Million |
| Market Capitalization | $31.61 Million USD |
Valuation Analysis
Above Book Valuation: The market values Precipio Inc's assets above their book value (1.86x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Precipio Inc's assets decreased by 6.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Precipio Inc (1999–2024)
The table below shows the annual total assets of Precipio Inc from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $17.00 Million | -6.10% |
| 2023-12-31 | $18.10 Million | -15.82% |
| 2022-12-31 | $21.50 Million | -29.35% |
| 2021-12-31 | $30.44 Million | +46.96% |
| 2020-12-31 | $20.71 Million | +6.16% |
| 2019-12-31 | $19.51 Million | -9.69% |
| 2018-12-31 | $21.61 Million | -20.74% |
| 2017-12-31 | $27.26 Million | +2065.21% |
| 2016-12-31 | $1.26 Million | -73.86% |
| 2015-12-31 | $4.82 Million | -83.95% |
| 2014-12-31 | $30.01 Million | -0.90% |
| 2013-12-31 | $30.28 Million | -21.95% |
| 2012-12-31 | $38.79 Million | +15.58% |
| 2011-12-31 | $33.56 Million | +4.79% |
| 2010-12-31 | $32.03 Million | +100.12% |
| 2009-12-31 | $16.00 Million | -8.84% |
| 2008-12-31 | $17.56 Million | -8.04% |
| 2007-12-31 | $19.09 Million | -10.66% |
| 2006-12-31 | $21.37 Million | -15.68% |
| 2005-12-31 | $25.34 Million | -32.35% |
| 2004-12-31 | $37.46 Million | -34.64% |
| 2003-12-31 | $57.31 Million | -22.60% |
| 2002-12-31 | $74.03 Million | -17.08% |
| 2001-12-31 | $89.29 Million | +14.67% |
| 2000-12-31 | $77.86 Million | +290.03% |
| 1999-12-31 | $19.96 Million | -- |
About Precipio Inc
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomar… Read more